Silicon Valley billionaires including Jeff Bezos, Peter Thiel, Yuri Milner, and Sam Altman have invested in cellular reprogramming for longevity. The technique has rejuvenated mice and monkeys but had never been tried in humans until this year. The first human trial is underway at Life Biosciences, where patients are being dosed. Early results suggest the approach may be working.
Related Articles
Don't miss out on breaking stories and in-depth articles.